CMV Research Study
Cytomegalovirus (CMV) affects people of all ages and is one of the most common viruses in the world. It is spread through bodily fluids, so simple things like kissing or sharing utensils can pass it from person to person. Infections from CMV can be more severe for those with weakened immune systems, infants, and the elderly. There is currently no cure for CMV, but clinical research may hold an important role in combating this virus and understanding how it works.
Centricity Research is currently conducting a study in your area for an investigational CMV vaccine.
- Healthy females between the ages of 16-40
- If age is ≥20, be in close contact with at least one child ≤5 for at least 8 hours a week
Compensation: Up to $1,494 may be available for qualified participants.
Study Duration: 30 months
Location: Centricity Research, 800 Talbotton Road, Columbus, GA 31904
You can learn more about this study by visiting clinicaltrials.gov and entering the protocol number mRNA-1647-P301.
or click Contact Form below and someone will contact you shortly!